Syndecans in inflammation

FASEB Journal

Volumn 17, Issue 6, 2003, Pages 575-591

  Götte, Martin ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Cell surface heparan sulfate; Chemokine; Cytokine; Growth factor; Leukocyte endothelial interaction

Indexed keywords

CHEMOKINE; CYTOKINE; GROWTH FACTOR; HEPARAN SULFATE; KININOGEN; MATRIX PROTEIN; SYNDECAN; MEMBRANE PROTEIN; PROTEOGLYCAN;

CELL ACTIVATION; CELL ADHESION; CELL INTERACTION; CELL MATURATION; CELL REGENERATION; CELL SURFACE; CELL TYPE; CHEMOTAXIS; ENDOTHELIUM; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INFLAMMATORY CELL; KNOCKOUT MOUSE; LEUKOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; REVIEW; TRANSGENIC MOUSE; ANIMAL; HUMAN; METABOLISM;

MAMMALIA; MUS MUSCULUS;

ANIMALS; CHEMOKINES; CYTOKINES; HEPARITIN SULFATE; HUMANS; INFLAMMATION; MEMBRANE GLYCOPROTEINS; PROTEOGLYCANS; SYNDECANS;

EID: 0037387945     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.02-0739rev     Document Type: Review

References (204)

1. Springer, T. A. (1995) Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu. Rev. Physiol. 57, 827-872
2. Marshall, D., and Haskard, D. O. (2002) Clinical overview of leukocyte adhesion and migration: where are we now? Semin. Immunol. 14, 133-140
3. Salek-Ardakani, S., Arrand, J. R., Shaw, D., and Mackett, M. (2000) Heparin and heparan sulfate bind interleukin-10 and modulate its activity. Blood 96, 1879-1888
4. Lortat-Jacob, H., Grosdidier, A., and Imberty, A. (2002) Structural diversity of heparan sulfate binding domains in chemokines. Proc. Natl. Acad. Sci. USA 99, 1229-1234
5. Wrenshall, L. E., and Platt, J. L. (1999) Regulation of T cell homeostasis by heparan sulfate-bound IL-2. J. Immunol. 163, 3793-3800
6. Lipscombe, R. J., Nakhoul, A. M., Sanderson, C. J., and Coombe, D. R. (1998) Interleukin-5 binds to heparin/heparan sulfate. A model for an interaction with extracellular matrix. J. Leukoc. Biol. 63, 342-350
7. Douglas, M. S., Rix, D. A., Dark, J. H., Talbot, D., and Kirby, J. A. (1997) Examination of the mechanism by which heparin antagonizes activation of a model endothelium by interferon-gamma (IFN-gamma). Clin. Exp. Immunol. 107, 578-584
8. Wagner, L., Yang, O. O., Garcia-Zepeda, E. A., Ge, Y., Kalams, S. A., Walker, B. D., Pasternack, M. S., and Luster, A. D. (1998) Beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans. Nature (London) 391, 908-911
9. Koenig, A., Norgard-Sumnicht, K., Linhardt, R., and Varki, A. (1998) Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents. J. Clin. Invest. 101, 877-889
10. Giuffre, L., Cordey, A. S., Monai, N., Tardy, Y., Schapira, M., and Spertini, O. (1997) Monocyte adhesion to activated aortic endothelium: role of L-selectin and heparan sulfate proteoglycans. J. Cell Biol. 136, 945-956
11. Hoogewerf, A.J., Kuschert, G. S., Proudfoot, A. E., Borlat, F., Clark-Lewis, I., Power, C. A., and Wells, T. N. (1997) Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochemistry 36, 13570-13578
12. Wrenshall, L. E., Stevens, R. B., Cerra, F. B., and Platt, J. L. (1999) Modulation of macrophage and B cell function by glycosaminoglycans. J. Leukoc. Biol. 66, 391-400
13. Miller, S. J., Hoggat, A. M., and Faulk, W. P. (1998) Heparin regulates ICAM-1 expression in human endothelial cells: an example of non-cytokine-mediated endothelial activation. Thromb. Haemost. 80, 481-487
14. Olofsson, A. M., Vestberg, M., Herwald, H., Rygaard, J., David, G., Arfors, K. E., Linde, V., Flodgaard, H., Dedio, J., Müller-Esterl, W., et al. (1999) Heparin-binding protein targeted to mitochondrial compartments protects endothelial cells from apoptosis. J. Clin. Invest. 104, 885-894
15. Renné, T., Dedio, J., David, G., and Müller-Esterl, W. (2000) High molecular weight kininogen utilizes heparan sulfate proteoglycans for accumulation on endothelial cells. J. Biol. Chem. 275, 33688-33696
16. Pillarisetti, S., Obunike, J. C., and Goldberg, U. (1995) Lysolecithin-induced alteration of subendothelial heparan sulfate proteoglycans increases monocyte binding to matrix. J. Biol. Chem. 270, 29760-29765
17. Kato, M., Wang, H., Kainulainen, V., Fitzgerald, M. L., Ledbetter, S., Ornitz, D. M., and Bernfield, M. (1998) Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2. Nat. Med. 4, 691-697
18. Clasper, S., Vekemans, S., Fiore, M., Plebanski, M., Wordsworth, P., David, G., and Jackson, D. G. (1999) Inducible expression of the cell surface heparan sulfate proteoglycan syndecan-2 (fibroglycan) on human activated macrophages can regulate fibroblast growth factor action. J. Biol. Chem. 274, 24113-24123
19. Pillarisetti, S. (2000) Lipoprotein modulation of subendothelial heparan sulfate proteoglycans (perlecan) and atherogenicity. Trends Cardiovasc. Med. 10, 60-65
20. Vestweber, D., and Blanks, J. (1999) Mechanisms that regulate the function of the selectins and their ligands. Physiol. Rev. 79, 181-213
21. Calros, T. M., and Harlan, J. M. (1994) Leukocyte-endothelial adhesion molecules. Blood 84, 2068-2101
22. Patel, K. D., Cuvelier, S. L., and Wiehler, S. (2002) Selectins: critical mediators of leukocyte recruitment. Semin. Immunol. 14, 73-81
23. Ley, K., Allietta, M., Bullard, D. C., and Morgan, S. (1998) Importance of E-selectin for firm leukocyte adhesion in vivo. Circ. Res. 83, 287-294
24. Alon, R., and Feigelson, S. (2002) From rolling to arrest on blood vessels: leukocyte tap dancing on endothelial integrin ligands and chemokines at sub-second contacts. Semin. Immunol. 14, 93-104
25. Constantin, G., Majeed, M., Giagulli, C., Piccio, L., Kim, J. Y., Butcher, E. C., and Laudanna, C. (2000) Chemokines trigger immediate beta2 integrin affinity and mobility changes: differential regulation and roles in lymphocyte arrest under flow. Immunity 13, 759-769
26. Weber, C., Kitayama, J., and Springer, T. A. (1996) Differential regulation of beta 1 and beta 2 integrin avidity by chemoattractants in eosinophils. Proc. Natl. Acad. Sci. USA 93, 10939-10944
27. Mackay, C. R. (2001) Chemokines: immunology's high impact factors. Nat. Immunol. 2, 95-101
28. Luster, A. D. (1998) Chemokines-chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338, 436-445
29. Miller, M. D., and Krangel, K. S. (1992) Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit. Rev. Immunol. 12, 17-46
30. Johnston, B., and Butcher, E. C. (2002) Chemokines in rapid leukocyte adhesion triggering and migration. Semin. Immunol. 14, 83-92
31. Vaday, G. G., Franitza, S., Schor, H., Hecht, I., Brill, A., Cahalon, L., Hershkoviz, L., and Lider, O. (2001) Combinatorial signals by inflammatory cytokines and chemokines mediate leukocyte interactions with extracellular matrix. J. Leukoc. Biol. 69, 885-892
32. Kitayama, J., Hidemura, A., Saito, H., and Nagawa, H. (2000) Shear stress affects migration behavior of polymorphonuclear cells arrested on endothelium. Cell. Immunol. 203, 39-46
33. Cinamon, G., Shinder, V., and Alon, R. (2002) Lymphocyte transendothelial migration: a shear-flow promoted chemokine-triggered process distinct from chemotaxis. Directions Sci. 1, 65-68
34. Cinamon, G., Shinder, V., and Alon, R. (2001) Shear forces promote lymphocyte migration across vascular endothelium bearing apical chemokines. Nat. Immunol. 2, 515-522
35. Ottonello, L., Dapino, P., Amelotti, M., Barbera, P., Arduino, N., Bertolotto, M., and Dallegri, F. (1998) Activation of neutrophil respiratory burst by cytokines and chemoattractants. Regulatory role of extracellular matrix glycoproteins. Inflamm. Res. 47, 345-350
36. Borgquist, J. D., Quinn, M. T., and Swain, S. D. (2002) Adhesion to extracellular matrix proteins modulates bovine neutrophil responses to inflammatory mediators. J. Leukoc. Biol. 71, 764-774
37. Swain, S. D., Rohn, T. T., and Quinn, M. T. (2002) Neutrophil priming in host defense: role of oxidants as priming agents. Antioxid. Redox Signal. 4, 69-83
38. Splettstoesser, W. D., and Schuff-Werner, P. (2002) Oxidative stress in phagocytes-"the enemy within". Microsc. Res. Tech. 57, 441-455
39. Bernfield, M., Kokenyesi, R., Kato, M., Hinkes, M. T., Spring, J., Gallo, R. L., and Lose, E. J. (1992) Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Annu. Rev. Cell Biol. 8, 365-393
40. Bernfield, M., Götte, M., Park, P. W., Reizes, O., Fitzgerald, M. L., Lincecum, J., and Zako, M. (1999) Functions of cell surface heparan sulfate proteoglycans. Annu. Rev. Biochem. 68, 729-777
41. Kim, C. W., Goldberger, O. A., Gallo, R. L., and Bernfield, M. (1994) Members of the syndecan family of heparan sulfate proteoglycans are expressed in distinct cell-, tissue-, and development-specific patterns. Mol. Biol. Cell 5, 797-805
42. Fitzgerald, M. L., Wang, Z., Park, P. W., Murphy, G., and Bernfield, M. (2000) Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase. J. Cell Biol. 148, 811-824
43. Rapraeger, A. (2000) Syndecan-regulated receptor signaling. J. Cell Biol. 149, 995-997
44. Ueno, M., Yamada, S., Zako, M., Bernfield, M., and Sugahara, K. (2001) Structural characterization of heparan sulfate and chondroitin sulfate of syndecan-1 purified from normal murine mammary gland epithelial cells. Common phosphorylation of xylose and differential sulfation of galactose in the protein linkage region tetrasaccharide sequence. J. Biol. Chem. 276, 29134-29140
45. Reizes, O., Lincecum, J., Wang, Z., Goldberger, O., Huang, L., Kaksonen, M., Ahima, R., Hinkes, M. T., Barsh, G. S., Rauvala, H., et al. (2001) Transgenic expression of syndecan-1 uncovers a physiological control of feeding behavior by syndecan-3. Cell 106, 105-116
46. Alexander C. M., Reichsman, F., Hinkes, M. T., Lincecum, J., Becker, K. A., Cumberledge, S., and Bernfield, M. (2000) Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice. Nat. Genet. 25, 329-332
47. Park, P. W., Pier, G. B., Hinkes, M. T., and Bernfield, M. (2001) Exploitation of syndecan-1 shedding by Pseudomonas aeruginosa enhances virulence. Nature (London) 411, 98-102
48. Salmivirta, M. Elenius, K., Vainio, S., Hofer, U., Chiquet-Ehrismann, R., Thesleff, I., and Jalkanen, M. (1991) Syndecan from embryonic tooth mesenchyme binds tenascin. J. Biol. Chem. 266, 7733-7739
49. Baciu, P. C., Saoncella, S., Lee, S. H., Denhez, F., Leuthardt, D., and Goetinck, P. F. (2000) Syndesmos, a protein that interacts with the cytoplasmic domain of syndecan-4, mediates cell spreading and actin cytoskeleton organization. J. Cell Sci. 113, 315-324
50. Grootjans, J. J., Zimmermann, P., Reekmans, G., Smets, A., Degeest, G., Durr, J., and David, G. (1997) Syntenin, a PDZ protein that binds syndecan cytoplasmic domains. Proc. Natl. Acad. Sci. USA 94, 13683-13688
51. Cohen, A. R., Woods, D. F., Marfatia, S. M., Walther, Z., Chishti, A. H., and Anderson, J. M. (1998) Human CASK/LIN-2 binds syndecan-2 and protein 4.1 and localizes to the basolateral membrane of epithelial cells. J. Cell Biol. 142, 129-138
52. Gao, Y., Li, M., Chen, W., and Simons, M. (2000) Protein Synectin, syndecan-4 cytoplasmic domain binding PDZ protein, inhibits cell migration. J. Cell. Physiol. 184, 373-379
53. Ethell, I. M., Hagihara, K., Miura, Y., Irie, F., and Yamaguchi, Y. (2000) Synbindin, a novel syndecan-2-binding protein in neuronal dendritic spines. J. Cell Biol. 151, 53-67
54. Horowitz, A., Tkachenko, E., and Simons, M. (2002) Fibroblast growth factor-specific modulation of cellular response by syndecan-4. J. Cell Biol. 157, 715-725
55. Woods, A., and Couchman, J. R. (2001) Syndecan-4 and focal adhesion function. Curr. Opin. Cell Biol. 13, 578-583
56. Simons, M., and Horowitz, A. (2001) Syndecan-4-mediated signalling. Cell. Signal. 13, 855-862
57. Lebakken, C. S., McQuade, K. J., and Rapraeger, A. C. (2000) Syndecan-1 signals independently of beta1 integrins during Raji cell spreading. Exp. Cell Res. 259, 315-325
58. Derksen, P. W., Keehnen, R. M., Evers, L. M., van Oers, M. H., Spaargaren, M., and Pals, S. T. (2002) Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma. Blood 99, 1405-1410
59. Seidel, C., Borset, M., Hjertner, O., Cao, D., Abildgaard, N., Hjorth-Hansen, H., Sanderson, R. D., Waage, A., and Sundan, A. (2000) High levels of syndecan-1 in myeloma-derived bone-marrow: modulation of hepatocyte growth factor activity. Blood 96, 3139-3146
60. Viklund, L., Loo, B. M., Hermonen, J., El-Darwish, K., Jalkanen, M., and Salmivirta, M. (2002) Expression and characterization of minican, a recombinant syndecan-1 with extensively truncated core protein. Biochem. Biophys. Res. Commun. 290, 146-152
61. Filmus, J., and Selleck, S. B. (2001) Glypicans: proteoglycans with a surprise. J. Clin. Invest. 108, 497-501
62. Iozzo, R. V., Cohen, I. R., Grässel, S., and Murdoch, A. D. (1994) The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices. Biochem. J. 302, 625-639
63. Gengrinovitch, S., Berman, B., David, G., Witte, L., Neufeld, G., and Ron, D. (1999) Glypican-1 is a VEGF165 binding protein which acts as an extracellular chaperone for VEGF165. J. Biol. Chem. 274, 10816-10822
64. Murakami, M., Yoshihara, K., Shimbara, S., Lambeau, G., Gelb, M. H., Singer, A. G., Sawada, M., Inagaki, N., Nagai, H., Ishihara, M., et al. (2002) Cellular arachidonate-releasing function and inflammation-associated expression of group IIF secretory phospholipase A2. J. Biol. Chem. 277, 19145-19155
65. Liu, W., Litwack, E. D., Stanley, M. J., Langford, J. K., Lander, A. D., and Sanderson, R. D. (1998) Heparan sulfate proteoglycans as adhesive and anti-invasive molecules. Syndecans and glypican have distinct functions. J. Biol. Chem. 273, 22825-22832
66. Iozzo, R. V. (1998) Matrix proteoglycans: from molecular design to cellular function. Annu. Rev. Biochem. 67, 609-652
67. Iozzo, R. V., and San Antonio, J. D. (2001) Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena. J. Clin. Invest. 108, 349-355
68. De Cat, B., and David, G. (2000) Developmental roles of the glypicans. Biochim. Biophys. Acta 1488, 59-70
69. Lindahl, U., Kusche-Gullberg, M., and Kjellén, L. (1998) Regulated diversity of heparan sulfate. J. Biol. Chem. 273, 24979-24982
70. Esko, J. D., and Lindahl, U. (2001) Molecular diversity of heparan sulfate. J. Clin. Invest. 108, 169-173
71. Lyon, M., and Gallagher, J. T. (1998) Biospecific sequences and domains in heparan sulphate and the regulation of cell growth and adhesion. Matrix Biol. 17, 485-493
72. Conrad, H. E. (1998) Heparin-binding Proteins, Academic Press, San Diego, CA
73. Forsberg, E., and Kjellén, L. (2001) Heparan sulfate: lessons from knockout mice. J. Clin. Invest. 108, 175-180
74. Merry, C. L. R., Bullock, S. L., Swan, D. C., Backen, A. C., Lyon, M., Beddington, R. S. P., Wilson, V. A., and Gallagher, J. T. (2001) The molecular phenotype of heparan sulfate in the Hs2st-/- mutant mouse. J. Biol. Chem. 276, 35429-35434
75. Lin, X., Wei, G., Shi, Z., Dryer, L., Esko, J. D., Wells, D. E., and Matzuk, M. M. (2000) Disruption of gastrulation and heparan sulfate biosynthesis in EXT1-deficient mice. Dev. Biol. 224, 299-311
76. Ringvall, M., Ledin, J., Holmborn, K., van Kuppevelt, T., Ellin, F., Eriksson, I., Olofsson, A. M., Kjellen, L., and Forsberg, E. (2000) Defective heparan sulfate biosynthesis and neonatal lethality in mice lacking N-deacetylase/N-sulfotransferase-1. J. Biol. Chem. 275, 25926-25930
77. Fan, G., Xiao, L., Cheng, L., Wang, X., Sun, B., and Hu, G. (2000) Targeted disruption of NDST-1 gene leads to pulmonary hypoplasia and neonatal respiratory distress in mice. FEBS Lett. 467, 7-11
78. Humphries, D. E., Wong, G. W., Friend, D. S., Gurish, M. F., Qiu, W. T., Huang, C., Sharpe, A. H., and Stevens, R. L. (1999) Heparin is essential for the storage of specific granule proteases in mast cells. Nature (London) 400, 769-772
79. Forsberg, E., Pejler, G., Ringvall, M., Lunderius, C., Tomasini-Johansson, B., Kusche-Gullberg, M., Eriksson, I., Ledin, J., Hellman, L., and Kjellen, L. (1999) Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme. Nature (London) 400, 773-776
80. Bullock, S. L., Fletcher, J. M., Beddington, R. S., and Wilson, V. A. (1998) Renal agenesis in mice homozygous for a gene trap mutation in the gene encoding heparan sulfate 2-sulfotransferase. Genes Dev. 12, 1894-1906
81. Luo, J., Kato, M., Wang, H., Bernfield, M., and Bischoff, J. (2001) Heparan sulfate and chondroitin sulfate proteoglycans inhibit E-selectin binding to endothelial cells. J. Cell. Biochem. 80, 522-531
82. Robinson, M.J., Tessier, P., Poulsom, R., and Hogg, N. (2002) The S100 family heterodimer, MRP-8/14, binds with high affinity to heparin and heparan sulfate glycosaminoglycans on endothelial cells. J. Biol. Chem. 277, 3658-3665
83. Gupta, P., Oegema, T. R., Brazil, J. J., Dudek, A. Z., Slungaard, A., and Verfaillie, C. M. (2000) Human LTC-IC can be maintained for at least 5 weeks in vitro when interleukin-3 and a single chemokine are combined with O-sulfated heparan sulfates: requirement for optimal binding interactions of heparan sulfate with early-acting cytokines and matrix proteins. Blood 95, 147-155
84. Jouan, V., Canron, X., Alemany, M., Caen, J. P., Quentin, G., Plouet, J., and Bikfalvi, A. (1999) Inhibition of in vitro angiogenesis by platelet factor-4-dreived peptides and mechanism of action. Blood 94, 984-993
85. Godiska, R., Chantry, D., Raport, C. J., Schweickart, V. L., Trong, H. L., and Gray, P. W. (1997) Monocyte chemotactic protein-4: tissue-specific expression and signaling through CC chemokine receptor-2. J. Leukoc. Biol. 61, 353-360
86. Götte, M., Joussen, A. M., Klein, C., André, P., Wagner, D. D., Kirchhof, B., Hinkes, M. T., Adamis, A. P., and Bernfield, M. (2002) Role of syndecan-1 in leukocyte-endothelial interactions in the ocular vasculature. Invest. Ophthalm. Vis. Sci. 43, 1135-1141
87. Ishiguro, K., Kadomatsu, K., Kojima, T., Muramatsu, H., Iwase, M., Yoshikai, Y., Yanada, M., Yamamoto, K., Matsushita, T., Nishimura, M., et al. (2001) Syndecan-4 deficiency leads to high mortality of lipopolysaccharide-injected mice. J. Biol. Chem. 276, 47483-47488
88. Schofield, K. P., Gallagher, J. T., and David, G. (1999) Expression of proteoglycan core proteins in human bone marrow stroma. Biochem. J. 343, 663-668
89. Coombe, D. R., Watt, S. M., and Parish, C. R. (1994) Mac-1 (CD11b/CD18) and CD45 mediate the adhesion of hematopoietic progenitor cells to stromal cell elements via recognition of stromal heparan sulfate. Blood 84, 739-752
90. Alvarez-Silva, A., and Borojevic, R. (1996) GM-CSF and IL-3 activities in schistosomal liver granulomas are controlled by stroma-associated heparan sulfate proteoglycans. J. Leukoc. Biol. 59, 435-441
91. Wrenshall, L. E., Cerra, F. B., Rubinstein, P., and Platt, J. L. (1993) Regulation by heparan sulfate and interleukin 1 alpha of the ontogenic expression of T-cell receptor, CD4, and CD8 in developing thymus. Hum. Immunol. 38, 165-171
92. Borghesi, L. A., Yamashita, Y., and Kincade, P. W. (1999) Heparan sulfate proteoglycans mediate interleukin-7 dependent B lymphopoiesis. Blood 93, 140-148
93. Kodaira, Y., Nair, S. K., Wrenshall, L. E., Gilboa, E., and Platt, J. L. (2000) Phenotypic and functional maturation of dendritic cells mediated by heparan sulfate. J. Immunol. 165, 1599-1604
94. Wrenshall, L. E., Cerra, F. B., Singh, R. K., and Platt, J. L. (1995) Heparan sulfate initiates signals in murine macrophages leading to divergent biologic outcomes. J. Immunol. 154, 871-880
95. Patel, D. D., Koopmann, W., Imai, T., Whichard, L. P., Yoshie, O., and Krangel, M. S. (2001) Chemokines have diverse abilities to form solid phase gradients. Clin. Immunol. 99, 43-52
96. Wrenshall, L. E., Carlson, A., Cerra, F. B., and Platt, J. L. (1994) Modulation of cytolytic T cell responses by heparan sulfate. Transplantation 57, 1087-1094
97. Tanaka, Y., Kimata, K., Wake, A., Mine, S., Morimoto, I., Yamakawa, N., Habuchi, H., Ashikari, S., Yamamoto, H., Sakurai, K., et al. (1996) Heparan sulfate proteoglycan on leukemic cells is primarily involved in integrin triggering and its mediated adhesion to endothelial cells. J. Exp. Med. 184, 1987-1997
98. Webb, L. M., Ehrengruber, M. U., and Clark-Lewis, I. (1993) Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8. Proc. Natl. Acad. Sci. USA 90, 7158-7162
99. Middleton, J., Neil, S., Wintle, J., Clark-Lewis, I., Moore, H., Lam, C., Auer, M., Hub, E., and Rot, A. (1997) Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell 91, 385-395
100. Goger, B., Halden, Y., Rek, A., Mosl, R., Pye, D., Gallagher, J., and Kungl, A. J. (2002) Different affinities of glycosaminoglycan oligosaccharides for monomeric and dimeric interleukin-8: a model for chemokine regulation at inflammatory sites. Biochemistry 41, 1640-1646
101. Kitamura, N., Yamaguchi, M., Shimabukuro, K., Miyasaka, M., Nakano, H., and Kumada, K. (1996) Heparin-like glycosaminoglycans inhibit leukocyte adhesion to endotoxin-activated human vascular endothelial cells under nonstatic conditions. Eur. Surg. Res. 28, 428-435
102. Johnson, P., Maiti, A., Brown, K. L., and Li, R. (2000) A role for the cell adhesion molecule CD44 and sulfation in leukocyte-endothelial cell adhesion during an inflammatory response? Biochem. Pharmacol. 59, 455-465
103. Kawashima, H., Atarashi, K., Hirose, M., Hirose, J., Yamada, S., Sugahara, K., and Miyasaka, M. (2002) Oversulfated chondroitin/dermatan sulfates containing GlcA beta 1/IdoA alpha 1-3GalNAc(4,6-O-disulfate) interact with L- and P-selectin and chemokines. J. Biol. Chem. 277, 12921-12930
104. Xie, X., River, A.-S., Zakrzewicz, A., Bernimoulin, M., Zeng, X.-L., Wessel, H. P., Schapira, M., and Spertini, O. (2000) Inhibition of selectin-mediated cell adhesion and prevention of acute inflammation by nonanticoagulant sulfated saccharides. J. Biol. Chem. 275, 34818-34825
105. Wan, M. X., Zhang, X. W., Torkvist, L., and Thorlacius, H. (2001) Low molecular weight heparin inhibits tumor necrosis factor alpha-induced leukocyte rolling. Inflamm. Res. 50, 581-584
106. Diamond, M. S., Alon, R., Parkos, C. A., Quinn, M. T., and Springer, T. A. (1995) Heparin is an adhesive ligand for the leukocyte integrin Mac-1 (CD11b/CD1). J. Cell Biol. 130, 1473-1482
107. Peter, K., Schwarz, M., Conradt, C., Nordt, T., Moser, M., Kubler, W., and Bode, C. (1999) Heparin inhibits ligand binding to the leukocyte integrin Mac-1 (CD11b/CD18). Circulation 100, 1533-1539
108. Clemetson, K. J., Clemetson, J. M., Proudfoot, A. E. I., Power, C. A., Baggiolini, M., and Wells, T. N. C. (2000) Functional expression of CCR1, CCR3, CCR4 and CXCR4 chemokine receptors on human platelets. Blood 96, 4046-4054
109. Perollet, C., Han, Z. C., Savona, C., Caen, J. P., and Bikfalvi, A. (1998) Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization. Blood 91, 3289-3299
110. Nelson, R. M., Venot, A., Bevilacqua, M. P., Linhardt, R. J., and Stamenkovic, I. (1995) Carbohydrate-protein interactions in vascular biology. Annu. Rev. Cell Dev. Biol. 11, 601-631
111. Ali, S., Palmer, A. C., Fritchley, S. J., Maley, Y., and Kirby, J. A. (2001) Multimerization of monocyte chemoattractant protein-1 is not required for glycosaminoglycan-dependent transendothelial chemotaxis. Biochem. J. 358, 737-745
112. Gambero, A., Landucci, E. C., Toyama, M. H., Marangoni, S., Giglio, J. R., Nader, H. B., Dietrich, C. P., De Nucci, G., and Antunes, E. (2002) Human neutrophil migration in vitro induced by secretory phospholipases A2: a role for cell surface glycosaminoglycans. Biochem. Pharmacol. 63, 65-72
113. Bame, K. J. (2001) Heparanases: endoglycosidases that degrade heparan sulfate proteoglycans. Glycobiology 11, 91R-98R
114. Bartlett, M. R., Cowden, W. B., and Parish, C. R. (1995) Differential effects of the anti-inflammatory compounds heparin, mannose-6-phosphate, and castanospermine on degradation of the vascular basement membrane by leukocytes, endothelial cells, and platelets. J. Leukoc. Biol. 57, 207-213
115. Goldshmidt, G. Zcharia, E., and Vlodavski, I. (2002) Involvement of heparanase in cancer metastasis and angiogenesis. Directions Sci. 1, 73-76
116. Parish, C. R., Hindmarsh, E. J., Bartlett, M. R., Staykova, M. A., Cowden, W. B., and Willenborg, D. O. (1998) Treatment of central nervous system inflammation with inhibitors of basement membrane degradation. Immunol. Cell Biol. 76, 104-113
117. Ihrcke, N. S., Parker, W., Reissner, K. J., and Platt, J. L. (1998) Regulation of platelet heparanase during inflammation: role of pH and proteinases. J. Cell. Physiol. 175, 255-267
118. Dempsey, L. A., Plummer, T. B., Coombes, S. L., and Platt, J. L. (2000) Heparanase expression in invasive trophoblasts and acute vascular damage. Glycobiology 10, 467-475
119. Ishai-Michaeli, R., Eldor, A., and Vlodavsky, I. (1990) Heparanase activity expressed by platelets, neutrophils, and lymphoma cells releases active fibroblast growth factor from extracellular matrix. Cell Regul. 1, 833-842
120. Jaakkola, P., and Jalkanen, M. (1999) Transcriptional regulation of Syndecan-1 expression by growth factors. Prog. Nucleic Acid Res. Mol. Biol. 63, 109-138
121. Sneed, T. B., Stanley, D. J., Young, L. A., and Sanderson, R. D. (1994) Interleukin-6 regulates expression of the syndecan-1 proteoglycan on B lymphoid cells. Cell. Immunol. 153, 456-467
122. Bayer-Garner, I. B., and Korourian, S. (2001) Plasma cells in chronic endometritis are easily identified when stained with syndecan-1. Mod. Pathol. 14, 877-879
123. Sanderson, R. D., Lalor, P., and Bernfield, M. (1989) B lymphocytes express and lose syndecan at specific stages of differentiation. Cell Regul. 1, 27-35
124. Yeaman, C., and Rapraeger, A. C. (1993) Post-transcriptional regulation of syndecan-1 expression by cAMP in peritoneal macrophages. J. Cell Biol. 122, 941-950
125. Borset, M., Hjertner, O., Yaccoby, S., Epstein, J., and Sanderson, R. D. (2000) Syndecan-1 is targeted to the uropods of polarized myeloma cells where it promotes adhesion and sequesters heparin-binding proteins. Blood 96, 2528-2536
126. Sanderson, R. D., and Borset, M. (2002) Syndecan-1 in B lymphoid malignancies. Ann. Hematol. 81, 125-135
127. Lacy, H. M., and Sanderson, R. D. (2001) Sperm protein 17 is expressed on normal and malignant lymphocytes and promotes heparan sulfate-mediated cell-cell adhesion. Blood 98, 2160-2165
128. Saphire, A. C. S., Bobardt, M. D., Zhang, Z., David, G., and Gallay, P. A. (2001) Syndecans serve as attachment receptors for human immunodeficiency virus type 1 on macrophages. J. Virol. 75, 9187-9200
129. Boehm, T., Folkman, J., Browder, T., and O'Reilly, M. S. (1997) Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature (London) 390, 404-407
130. Elenius, K., Vainio, S., Laato, M., Salmivirta, M., Thesleff, I., and Jalkanen, M. (1991) Induced expression of syndecan in healing wounds. J. Cell Biol. 114, 585-595
131. Gallo, R., Kim, C., Kokenyesi, R., Adzick, N. S., and Bernfield, M. (1996) Syndecans-1 and -4 are induced during wound repair of neonatal but not fetal skin. J. Invest. Dermatol. 107, 676-683
132. Li, J., Brown, L. F., Laham, R. J., Volk, R., and Simons, M. (1997) Macrophage-dependent regulation of syndecan gene expression. Circ. Res. 81, 785-796
133. Kainulainen, V., Nelimarkka, L., Järvelainen, H., Laato, M., Jalkanen, M., and Elenius, K. (1996) Suppression of syndecan-1 expression in endothelial cells by tumor necrosis factor-alpha. J. Biol. Chem. 271, 18759-18766
134. André, P., Denis, C. V., Ware, J., Saffaripour, S., Hynes, R. O., Ruggeri, Z. M., and Wagner, D. D. (2000) Platelets adhere to and translocate on von Willebrand factor presented by endothelium in stimulated veins. Blood 96, 3322-3328
135. Mayadas, T. N., Johnson, R. C., Rayburn, H., Hynes, R. O., and Wagner, D. D. (1993) Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice. Cell 74, 541-554
136. Denis, C. V., André, P., Saffaripour, S., and Wagner, D. D. (2001) Defect in regulated secretion of P-selectin affects leukocyte recruitment in von Willebrand factor-deficient mice. Proc. Natl. Acad. Sci. USA 98, 4072-4077
137. Frenette, P. S., Johnson, R. C., Hynes, R. O., and Wagner, D. D. (1995) Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin. Proc. Natl. Acad. Sci. USA 92, 7450-7454
138. Etzioni, A., Doerschuk, C. M., and Harlan, J. M. (1999) Of man and mouse: leukocyte and endothelial adhesion molecule deficiencies. Blood 94, 3281-3288
139. Dawson, T. C., Lentsch, A. B., Wang, Z., Cowhig, J. E., Rot, A., Maeda, N., and Peiper, S. C. (2000) Exaggerated response to endotoxin in mice lacking the Duffy antigen/receptor for chemokines (DARC). Blood 96, 1681-1684
140. Hadley, T. J., and Peiper, S. C. (1997) From malaria to chemokine receptor: the emerging physiologic role of the Duffy blood group antigen. Blood 89, 3077-3091
141. McCafferty, D. M., Craig, A. W., Senis, Y. A., and Greer, P. A. (2002) Absence of Fer protein-tyrosine kinase exacerbates leukocyte recruitment in response to endotoxin. J. Immunol. 168, 4930-4935
142. Kinnunen, T., Kaksonen, M., Saarinen, J., Kalkkinen, N., Peng, H. B., and Rauvala, H. (1998) Cortactin-Src kinase signaling pathway is involved in N-syndecan-dependent neurite outgrowth. J. Biol. Chem. 273, 10702-10708
143. Lider, O., Mekori, Y. A., Miller, T., Bar-Tana, R., Vlodavsky, I., Baharav, E., Cohen, I. R., and Naparstek, Y. (1990) Inhibition of T lymphocyte heparanase by heparin prevents T cell migration and T cell-mediated immunity. Eur. J. Immunol. 20, 493-499
144. Gautam, N., Olofsson, A. M., Herwald, H., Iversen, L. F., Lundgren-Akerlund, E., Hedquist, P., Arfors, K.-E., Flodgaard, H., and Lindbom, L. (2001) Heparin-binding protein (HBP/CAP37): a missing link in neutrophil-evoked alteration of vascular permeability. Nat. Med. 7, 1123-1127
145. Koch, A. E., Polverini, P. J., Kunkel, S. L., Harlow, L. A., DiPietro, L. A., Elner, V. M., Elner, S. G., and Strieter, R. M. (1992) Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258, 1798-1801
146. Weinstat-Saslow, D., and Steeg, P. S. (1994) Angiogenesis and colonization in the tumor metastatic process: basic and applied advances. FASEB J. 8, 401-407
147. Besner, G. E., Higashiyama, S., and Klagsbrun, M. (1990) Isolation and characterization of a macrophage-derived heparin-binding growth factor. Cell Regul. 1, 811-819
148. Burgess, W. H., and Maciag, T. (1989) The heparin-binding (fibroblast) growth factor family of proteins. Annu. Rev. Biochem. 58, 575-606
149. Leung, D. W., Cachianes, G., Kuang, W. J., Goeddel, D. V., and Ferrara, N. (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246, 1306-1309
150. Moromizato, Y., Stechschulte, S., Miyamoto, K., Murata, T., Tsujikawa, A., Joussen, A. M., and Adamis, A. P. (2000) CD18 and ICAM-1-dependent corneal neovascularization and inflammation after limbal injury. Am. J. Pathol. 157, 1277-1281
151. Ribatti, D., Loria, M. P., and Tursi, A. (1991) Lymphocyte-induced angiogenesis: a morphometric study in the chick embryo chorioallantoic membrane. Acta Anat. (Basel) 142, 334-338
152. Day, R., and Forbes, A. (1999) Heparin, cell adhesion, and pathogenesis of inflammatory bowel disease. Lancet 354, 62-65
153. Day, R., Ilyas, M., Daszak, P., Talbot, I., and Forbes, A. (1999) Expression of syndecan-1 in inflammatory bowel disease and a possible mechanism of heparin therapy. Dig. Dis. Sci. 44, 2508-2515
154. Colgan, S. P., Comerford, K. M., and Lawrence, D. W. (2002) Epithelial cell-neutrophil interactions in the alimentary tract: a complex dialog in mucosal surveillance and inflammation. The Scientific World JOURNAL 2, 76-88
155. Furuta, G. T., Dzus, A. L., Taylor, C. T., and Colgan, S. P. (2000) Parallel induction of epithelial surface-associated chemokine and proteoglycan by cellular hypoxia: implications for neutrophil activation. J. Leukoc. Biol. 68, 251-259
156. Chowers, Y., Lider, O., Schor, H., Barshack, I., Tal, R., Ariel, A., Bar-Meir, S., Cohen, I. R., and Cahalon, L. (2001) Disaccharides derived from heparin of heparan sulfate regulate IL-8 and IL-1 beta secretion by intestinal epithelial cells. Gastroenterology 120, 449-459
157. Tanabe, H., Yokota, K., and Kohgo, Y. (1999) Localization of syndecan-1 in human gastric mucosa associated with ulceration. J. Pathol. 187, 338-344
158. Stepp, M. A., Gibson, H. E., Gala, P. H., Iglesia, D. D., Pajoohesh-Ganji, A., Pal-Ghosh, S., Brown, M., Aquino, C., Schwartz, A. M., Goldberger, O., et al. (2002) Defects in keratinocyte activation during wound healing in the syndecan-1-deficient mouse. J. Cell Sci. 115, 4517-4531
159. Ghosh, S., Hinkes, M., Bernfield, M., and Stepp, M. A. (2001) Changes in localization of beta-dystroglycan during corneal wound healing in normal and syndecan-1 deficient mice. Invest. Ophthalmol. Vis. Sci. 42, 4764 (S)
160. Worapamorn, W., Haase, H. R., Li, H., and Bartold, P. M. (2001) Growth factors and cytokines modulate gene expression of cell-surface proteoglycans in human periodontal ligament cells. J. Cell. Physiol. 186, 448-456
161. Manakil, J. F., Sugerman, P. B., Li, H., Seymour, G. J., and Bartold, P. M. (2001) Cell-surface proteoglycan expression by lymphocytes from peripheral blood and gingiva in health and periodontal disease. J. Dent. Res. 80, 1704-1710
162. Oksala, O., Haapasalmi, K., Hakkinen, L., Uitto, V. J., and Larjava, H. (1997) Expression of heparan sulphate and small dermatan/chondroitin sulphate proteoglycans in chronically inflamed human periodontium. J. Dent. Res. 76, 1250-1259
163. Götte, M., Kresse, H., and Hausser, H. (1995) Endocytosis of decorin by bovine aortic endothelial cells. Eur. J. Cell Biol. 66, 226-233
164. Yamashita Y., Oritani, K., Miyoshi, E. K., Wall, R., Bernfield, M., and Kincade, P. W. (1999) Syndecan-4 is expressed by B-lineage lymphocytes and can transmit a signal for formation of dendritic processes. J. Immunol. 162, 5940-5948
165. Yeaman, C., and Rapraeger, A. C. (1993) Membrane-anchored proteoglycans of mouse macrophages: P388D1 cells express a syndecan-4-like heparan sulfate proteoglycan and a distinct chondroitin sulfate form. J. Cell. Physiol. 157, 413-425
166. Kaneider, N. C., Egger, P., Dunzendorfer, S., and Wiedermann, C. J. (2001) Syndecan-4 as antithrombin receptor of human neutrophils. Biochem. Biophys. Res. Commun. 287, 42-46
167. Kaneider, N. C., Reinisch, C. M., Dunzendorfer, S., Römisch, J., and Wiedermann, C. J. (2002) Syndecan-4 mediates antithrombin-induced chemotaxis of human peripheral blood lymphocytes and monocytes. J. Cell Sci. 115, 227-236
168. Zhang, Y., Pasparakis, M., Kollias, G., and Simons, M. (1999) Myocyte-dependent regulation of endothelial cell syndecan-4 expression. Role of TNF-a. J. Biol. Chem. 274, 14786-14790
169. Uchiba, M., Okajima, K., Murakami, K., Okabe, H., and Takatsuki, K. (1996) Attenuation of endotoxin-induced pulmonary vascular injury by antithrombin III. Am. J. Physiol. 270, L921-L930
170. Hoffmann, J. N., Vollmar, B., Inthorn, D., Schildberg, F. W., and Menger, M. D. (2000) Antithrombin reduces leukocyte adhesion during chronic endotoxemia by modulation of the cyclooxygenase pathway. Am. J. Physiol. 279, C98-C107
171. Dunzendorfer, S., Kaneider, N., Rabensteiner, A., Meierhofer, C., Reinisch, C., Römisch, J., and Wiedermann, C. J. (2001) Cell-surface heparan sulfate proteoglycan-mediated regulation of human neutrophil migration by the serpin antithrombin III. Blood 97, 1079-1085
172. Saoncella, S., Echtermeyer, F., Denhez, F., Nowlen, J. K., Mosher, D. F. Stephen D. Robinson, S. D., Hynes, R. O., and Goetinck, P. F. (1999) Syndecan-4 signals cooperatively with integrins in a Rho-dependent manner in the assembly of focal adhesions and actin stress fibers. Proc. Natl. Acad. Sci. USA 96, 2805-2810
173. Ishiguro, K., Kadomatsu, K., Kojima, T., Muramatsu, H., Nakamura, E., Ito, M., Nagasaka, T., Kobayashi, H., Kusugami, K., Saito, H., et al. (2000) Syndecan-4 deficiency impairs the fetal vessels in the placental labyrinth. Dev. Dyn. 219, 539-544
174. Ishiguro, K., Kadomatsu, K., Kojima, T., Muramatsu, H., Tsuzuki, S., Nakamura, E., Kusugami, K., Saito, H., and Muramatsu, T. (2000) Syndecan-4 deficiency impairs focal adhesion formation only under restricted conditions. J. Biol. Chem. 275, 5249-5252
175. Johnson, A. N., and Newfeld, S. J. (2002) The TGF-β family: signalling pathways, developmental roles, and tumor suppressor activities. Sci. World J. 2, 892-925
176. Hausser, H., Gröning, A., Hasilik, A., Schönherr, E., and Kresse, H. (1994) Selective inactivity of TGF-beta/decorin complexes. FEBS Lett. 353, 243-245
177. Schönherr, E., and Hausser, H. J. (2000) Extracellular matrix and cytokines: a functional unit. Dev. Immunol. 7, 89-101
178. Lee, T. D., Gonzalez, L. M., Kumar, P., Chary-Reddy, S., Grammas, P., and Pereira, H. A. (2002) CAP37, a novel inflammatory mediator: its expression in endothelial cells and localization to atherosclerotic lesions. Am. J. Pathol. 16, 841-848
179. Pereira, H. A., Shafer, W. M., Pohl, J., Martin, L. E., and Spitznagel, J. K. (1990) CAP37, a human neutrophil-derived chemotactic factor with monocyte specific activity. J. Clin. Invest. 85, 1468-1476
180. Chertov, O., Michiel, D. F., Xu, L., Wang, J. M., Pereira, H. A., Taub, D. D., and Oppenheim, J. J. (1996) Identification of defensin-1, defensin-2, and azurocidin as T cell chemoattractant proteins released from IL-8-stimulated neutrophils. J. Biol. Chem. 271, 2935-2940
181. Heinzelmann, M., Platz, A. Flodgaard, H., Polk, H. C., Jr., and Miller, F. N. (1999) Endocytosis of heparin-binding protein (CAP37) is essential for the enhancement of lipopolysaccharide-induced TNF-alpha production in human monocytes. J. Immunol. 162, 4240-4245
182. Fuki, I. V., Kuhn, K. M., Lomazov, I. R., Rothman, V. L., Tuszynski, G. P., Iozzo, R. V., Swenson, T. L., Fisher, E. A., and Williams, K. J. (1997) The syndecan family of proteoglycans. Novel receptors mediating internalization of atherogenic lipoproteins in vitro. J. Clin. Invest. 100, 1611-1622
183. Fuki, I. V., Meyer, M. E., and Williams, K.J. (2000) Transmembrane and cytoplasmic domains of syndecan mediate a multistep endocytic pathway involving detergent-insoluble membrane rafts. Biochem. J. 351, 607-612
184. Roghani, M., and Moscatelli, D. (1992) Basic fibroblast growth factor is internalized through both receptor-mediated and heparan sulfate-mediated mechanisms. J. Biol. Chem. 267, 22156-22162
185. Sebestyen, A., Gallai, M., Knittel, T., Ambrust, T., Ramadori, G., and Kovalszky, I. (2000) Cytokine regulation of syndecan expression in cells of liver origin. Cytokine 12, 1557-1560
186. Modrowski, D., Basle, M., Lomri, A., and Marie, P. J. (2000) Syndecan-2 is involved in the mitogenic activity and signaling of granulocyte-macrophage colony-stimulating factor in osteoblasts. J. Biol. Chem. 275, 9178-9185
187. Kosher, R. A. (1998) Syndecan-3 in limb skeletal development. Microsc. Res. Tech. 43, 123-130
188. Lauri, S. E., Kaukinen, S., Kinnunen, T., Ylinen, A., Imai, S., Kaila, K., Taira, T., and Rauvala, H. (1999) Regulatory role and molecular interactions of a cell-surface heparan sulfate proteoglycan (N-syndecan) in hippocampal long-term potentiation. J. Neurosci. 19, 1226-1235
189. Clark, R. A. F. (ed.) (1996) The Molecular and Cellular Biology of Wound Repair. Plenum, second edition
190. Lundqvist, K., and Schmidtchen, A. (2001) Immunohistochemical studies on proteoglycan expression in normal skin and chronic ulcers. Br. J. Dermatol. 144, 254-259
191. Gallo, R. L., Ono, M., Povsic, T., Page, C., Eriksson, E., Klagsbrun, M., and Bernfield, M. (1994) Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds. Proc. Natl. Acad. Sci. USA 91, 11035-11039
192. Jacobs, W., Kumar-Singh, S., Bogers, J., Van de Vijver, K., Deelder, A., and Van Marck, E. (1998) Transforming growth factor-beta, basement membrane components and heparan sulphate proteoglycans in experimental hepatic schistosomiasis mansoni. Cell Tissue Res. 292, 101-106
193. Kainulainen, V. (1998) Syndecans in tissue injury (academic dissertation). In Annales Universitatis Turkuensis, Painosalama Oy, Turku, Finland
194. Echtermeyer, F., Streit, M., Wilcox-Adelman, S., Saoncella, S., Denhez, F., Detmar, M., and Goetinck, P. (2001) Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4. J. Clin. Invest. 107, R9-R14
195. Luster, A. D., Cardiff, R. D., MacLean, J. A., Crowe, K., and Granstein, R. D. (1998) Delayed wound healing and disorganized neovascularization in transgenic mice expressing the IP-10 chemokine. Proc. Assoc. Am. Phys. 110, 183-196
196. Kainulainen, V., Wang, H., Schick, C., and Bernfield, M. (1998) Syndecans, heparan sulfate proteoglycans, maintain the proteolytic balance of acute wound fluids. J. Biol. Chem. 273, 11563-11569
197. Subramanian, S. V., Fitzgerald, M. L., and Bernfield, M. (1997) Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and growth factor receptor activation. J. Biol. Chem. 272, 14713-14720
198. Kheradmand, F., and Werb, Z. (2002) Shedding light on sheddases: role in growth and development. Bioessays 24, 8-12
199. Herren, B. (2002) ADAM-mediated shedding and adhesion: a vascular perspective. News Physiol. Sci. 17, 73-76
200. Dello, S. P., and Rovida, E. (2002) Transmodulation of cell surface regulatory molecules via ectodomain shedding. Biol. Chem. 383, 69-83
201. Holen, I., Drury, N. L., Hargreaves, P. G., and Croucher, P. I. (2001) Evidence of a role for a non-matrix-type metalloproteinase activity in the shedding of syndecan-1 from human myeloma cells. Br. J. Haematol. 114, 414-421
202. Ihrcke, N. S., Wrenshall, L. E., Lindman, B. J., and Platt, J. L. (1993) Role of heparan sulfate in immune system-blood vessel interactions. Immunol. Today 14, 500-505
203. Ihrcke, N. S., and Platt, J. L. (1996) Shedding of heparan sulfate proteoglycan by stimulated endothelial cells: evidence for proteolysis of cell-surface molecules. J. Cell. Physiol. 168, 625-637
204. Watchorn, T. M., Waddell, I., and Ross, J. A. (2002) Proteolysis-inducing factor differentially influences transcriptional regulation in endothelial subtypes. Am. J. Physiol. 282, E763-E769